INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $41,221 | -50.4% | 50,270 | -5.7% | 0.00% | -40.0% |
| Q4 2022 | $83,190 | -3.3% | 53,327 | +7.2% | 0.01% | -16.7% |
| Q3 2022 | $86,000 | -8.5% | 49,733 | -8.4% | 0.01% | +20.0% |
| Q2 2022 | $94,000 | -36.5% | 54,307 | +32.0% | 0.01% | -37.5% |
| Q1 2022 | $148,000 | -6.3% | 41,156 | +30.4% | 0.01% | -20.0% |
| Q4 2021 | $158,000 | -21.4% | 31,567 | +12.5% | 0.01% | -9.1% |
| Q3 2021 | $201,000 | -11.5% | 28,048 | +14.6% | 0.01% | -8.3% |
| Q2 2021 | $227,000 | +26.8% | 24,478 | +27.2% | 0.01% | +20.0% |
| Q1 2021 | $179,000 | +7.8% | 19,247 | +2.7% | 0.01% | -16.7% |
| Q4 2020 | $166,000 | -68.1% | 18,735 | -58.3% | 0.01% | -29.4% |
| Q3 2020 | $521,000 | -89.2% | 44,942 | -75.0% | 0.02% | -86.4% |
| Q2 2020 | $4,838,000 | – | 179,512 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |